Due to the small sample size of NONO-TFE3 tRCC in the validation cohort, we were limited to firmly establish the link between circMET upregulation and prognosis. Here, TFE3 is linked to renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions.